European Archives - Page 481 of 1351 - European Medical Journal

Reimagining Myasthenia Gravis Care

Myasthenia gravis (MG) is an autoimmune disease caused by autoantibodies targeting proteins on the neuromuscular junction. Around 85%…

Supporting Those Living With PBC

This series of short videos provides an overview of the key considerations for addressing the needs of those living with primary biliary…

A Project to Favour the Inclusion of People with Epilepsy in Workplaces

Despite good seizure control, unemployment and underemployment are more common among people with epilepsy (PwE) for several…

The latest edition of EMJ Neurology

Stay ahead of the curve with the newest issue of our Neurology journal, featuring a pioneering initiative for people with epilepsy…

Advancements in the Early Identification and Treatment of Alzheimer’s Disease

THIS YEAR marked the 10th Congress of the European Academy of Neurology (EAN), hosted in Helsinki, Finland, from 29th June–2nd July 2024…

Automatic Method for Jitter Estimation in Electromyographic Signals

Neurophysiological jitter measurement using concentric needle electrodes is a laborious and difficult task because potentials from…

Update on Daridorexant for Insomnia

During this symposium, held at the 10th Congress of the European Academy of Neurology (EAN), speakers highlighted that chronic insomnia…

Invasive Neuromodulation: Present and Future

NEUROMODULATION was the overarching theme of the European Academy of Neurology (EAN) Congress 2024, held from 29th June–2nd…

Idebenone Treatment for Leber Hereditary Optic Neuropathy

Leber hereditary optic neuropathy (LHON) is a mitochondrial disease resulting in bilateral central vision loss, primarily caused by one…

Nipocalimab and gMG: Top Line Results from the Phase III Vivacity-MG3 Study

Nipocalimab, a high-affinity, fully human, aglycosylated, effectorless, monoclonal antibody, has been developed as an add-on treatment…